Fortrea Holdings Inc. (FTRE) has shared an announcement.
Fortrea Holdings Inc. has successfully completed the sale of its Enabling Services division, which includes Endpoint Clinical and Fortrea Patient Access, to Arsenal Capital Partners. The deal was finalized at a price of $295 million with an additional $45 million contingent on meeting transition-related goals. This strategic divestiture marks a significant step for the company as it reshapes its business portfolio.
See more data about FTRE stock on TipRanks’ Stock Analysis page.
